PETACH TIKVA, Israel, Sept. 22, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Company’s management will present at the Cantor Global Healthcare Conference taking place on September 26-28, 2023, in New York City, New York.
Cantor Global Healthcare Conference:
Presentation Date: | Thursday, September 28, 2023 |
Presentation Time: | 8:00 AM Eastern Time |
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid during the conference should contact their Cantor representative.
About PolyPid
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn.
Contacts:
PolyPid Ltd.
Ori Warshavsky
COO – US
908-858-5995
IR@Polypid.com
Investors:
Brian Ritchie
LifeSci Advisors
212-915-2578
britchie@lifesciadvisors.com
Federal Government Approves Loan Program up to $80,000 for Home Garden Suite for HomeownersToronto, Ontario--(Newsfile…
Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium BALTIMORE…
In Motion has been a prominent leader of physical therapy services in the Downingtown community for…
PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- Qualified Health today announced its launch with…
SAN FRANCISCO, Jan. 8, 2025 /PRNewswire/ -- TryStrata, Inc. (Strata), a technology company for doctors,…
Investment in the low triple-digit million Euro rangeSignificant capacity increase with multiple new production linesCustomized…